- Home
- AUTL vs CYH Comparison
AUTL vs CYH Comparison
Compare AUTL & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- CYH
- Stock Information
- Founded
- AUTL 2014
- CYH 1985
- Country
- AUTL United Kingdom
- CYH United States
- Employees
- AUTL N/A
- CYH N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- CYH Hospital/Nursing Management
- Sector
- AUTL Health Care
- CYH Health Care
- Exchange
- AUTL Nasdaq
- CYH Nasdaq
- Market Cap
- AUTL 590.8M
- CYH 623.8M
- IPO Year
- AUTL 2018
- CYH 1991
- Fundamental
- Price
- AUTL $2.16
- CYH $3.34
- Analyst Decision
- AUTL Strong Buy
- CYH Hold
- Analyst Count
- AUTL 3
- CYH 6
- Target Price
- AUTL $10.20
- CYH $4.40
- AVG Volume (30 Days)
- AUTL 1.2M
- CYH 1.7M
- Earning Date
- AUTL 03-13-2025
- CYH 02-18-2025
- Dividend Yield
- AUTL N/A
- CYH N/A
- EPS Growth
- AUTL N/A
- CYH N/A
- EPS
- AUTL N/A
- CYH N/A
- Revenue
- AUTL $10,091,000.00
- CYH $12,551,000,000.00
- Revenue This Year
- AUTL $851.83
- CYH $1.16
- Revenue Next Year
- AUTL $264.18
- CYH $1.18
- P/E Ratio
- AUTL N/A
- CYH N/A
- Revenue Growth
- AUTL 82.71
- CYH 0.81
- 52 Week Low
- AUTL $2.07
- CYH $2.51
- 52 Week High
- AUTL $7.37
- CYH $6.29
- Technical
- Relative Strength Index (RSI)
- AUTL 36.29
- CYH 56.89
- Support Level
- AUTL $2.18
- CYH $2.88
- Resistance Level
- AUTL $2.38
- CYH $3.04
- Average True Range (ATR)
- AUTL 0.15
- CYH 0.14
- MACD
- AUTL 0.01
- CYH 0.06
- Stochastic Oscillator
- AUTL 6.57
- CYH 88.29
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.